Related Experiment Video
Updated: Jan 31, 2026

Identification of Alternative Splicing and Polyadenylation in RNA-seq Data
Published on: June 24, 2021
Identification of gene signatures from RNA-seq data using Pareto-optimal cluster algorithm.
Saurav Mallik1, Zhongming Zhao2,3
1Center for Precision Health, School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, 77030, TX, USA.
This study introduces a novel framework for identifying gene signatures from RNA-seq data using Pareto-optimal clustering. The method effectively classifies disease samples with high accuracy, offering a powerful tool for molecular diagnostics.
Area of Science:
- Genomics and Bioinformatics
- Computational Biology
- Molecular Diagnostics
Background:
- Gene signatures are crucial for understanding disease mechanisms and classifying samples.
- Existing methods often struggle with complex data and identifying the most informative gene signatures.
- There is a need for powerful, data-driven approaches to detect robust gene signatures.
Purpose of the Study:
- To develop and validate a novel framework for identifying gene signatures from RNA-seq data.
- To utilize multi-objective optimization for robust cluster size identification.
- To establish a gene signature capable of accurate disease classification.
Main Methods:
- A framework combining pre-filtering, normalization, and differential gene expression analysis (Limma) was employed.
- Multi-objective optimization for collecting cluster alternatives (MOCCA) identified Pareto-optimal cluster sizes.
- K-means clustering and Spearman's Correlation Score were used to determine the best gene signature cluster.
Main Results:
- The framework was applied to cervical cancer RNA-seq data, identifying 582 differentially expressed genes (DEGs).
- MOCCA yielded seven Pareto-optimal clusters, with the best cluster containing 35 upregulated DEGs.
- The identified gene signature achieved high classification performance (accuracy 0.935) using PAMR.
Conclusions:
- The developed framework successfully identifies a multi-objective optimized gene signature for disease classification.
- This signature demonstrates high accuracy in distinguishing disease and control samples.
- The method is broadly applicable to RNA-seq and microarray data for signature discovery.
More Related Videos
09:26Identification of Footprints of RNA:Protein Complexes via RNA Immunoprecipitation in Tandem Followed by Sequencing RIPiT-Seq
Published on: July 10, 2019
05:07Rup (RNA-seq Usability Assessment Pipeline) - Quality Control for Bulk RNA-seq Experiments in Eukaryotes
Published on: November 7, 2025
Related Concept Videos
RNA-seq
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
Pareto Chart
The Pareto chart is named after the Italian economist Vilfredo Pareto, who described the Pareto...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Trial and Error and Algorithm
RNA Splicing
Eukaryotic RNA Polymerases
All three eukaryotic RNAPs require specific transcription factors, of which the...